BDLIB
EW icon

Banque de Luxembourg Investments (BLI)’s Edwards Lifesciences EW Stock Holding History

Banque de Luxembourg Investments (BLI)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.4M Hold
169,530
– – 0.43% 62
2025
Q4 		$14.6M Buy
+169,530
New +$13.9M 0.43% 63
2025
Q3 		– Sell
-61,500
Closed -$4.81M – 175
2025
Q2 		$4.81M Buy
+61,500
New +$4.59M 0.14% 125

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Banque de Luxembourg Investments (BLI)'s EW Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its Edwards Lifesciences (EW) position steady in Q1 2026 at 169,530 shares worth $14.4M. The position accounts for 0.43% of the portfolio, ranked #62.

Banque de Luxembourg Investments (BLI) first reported a position in EW in Q2 2025 and has held it in 3 quarters since. The position peaked at $14.6M in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 169,530 shares of Edwards Lifesciences worth $14.4M as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.43% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #62 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 3 quarters since.
  • Banque de Luxembourg Investments (BLI)'s Edwards Lifesciences position peaked at $14.6M in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.